Navigation Links
Sublingual immunotherapy for inhalant allergies deserves deeper consideration
Date:4/29/2009

Alexandria, VA Sublingual immunotherapy for the treatment of allergy symptoms caused by a wide variety of environmental inhalants has been effectively used in Europe. It should be employed to further treatment of allergies in the United States, where allergic symptoms are largely undertreated, according to an invited article in the April 2009 issue of Otolaryngology-Head and Neck Surgery. A response to the article, published in the same journal issue, expresses cautious optimism, but calls for additional research.

Sublingual immunotherapy (SLIT) involves the administering of an allergen solution under the tongue, which in time reduces the patient's sensitivity to those allergens. The more prevalent alternative is subcutaneous immunotherapy, usually administered through an injection.

The authors of the invited article note that despite allergic symptoms contributing heavily to poor quality of life, high socioeconomic costs, and increased health issues, these syndromes remain underdiagnosed and undertreated. The authors attribute this to a public attitude that trivializes allergic conditions, along with patients' general dissatisfaction with the conventional pharmacy-based ways of treating allergic conditions. They conclude that the extensive implementation of SLIT treatment in Europe has proven to overcome these shortcomings in reaching patients, and the treatment is supported with significant literature documenting its efficacy, along with extensive clinical experience.

In a response to the invited article, AAO-HNSF Board of Directors member John H. Krouse, MD, PhD, recognizes the promising data associated with SLIT treatment, but urges caution until several issues can be addressed. Specifically, Dr. Krouse offers five areas of concern with SLIT treatment: patient selection; pattern of sensitization; dosing, preparation, and delivery; safety; and the financial cost of therapy. He concludes by noting the existence of a gap in allergy m
'/>"/>

Contact: Matt Daigle
newsroom@entnet.org
703-535-3754
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
2. Oral Allergy Immunotherapy Helps Control Asthma
3. Radioimmunotherapy After Chemo Safe for Common Lymphoma
4. Immunotherapy: enlisting the immune system to fight cancer
5. FDA Says, Wait To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy
6. Dangerous Side Effect Found in Cancer Immunotherapy Research
7. Latest research on allergies: Specific immunotherapy can help
8. OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness
9. Educational Symposium to Present Panel Discussion on Melanoma Treatments and Immunotherapy
10. Towards improved immunotherapy
11. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email: